Hanish Arnold C's Form 4 filing
Decoy Therapeutics Inc. (DCOY) · filed Jan 2, 2026
- Accession no.
- 0001615219-26-000004
- Filed
- Jan 2, 2026
- Trade date
- Dec 30, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.28. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hanish Arnold CCIK 0001233253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Common Stock | SSaleDisposed | −15 | $0.64 | −$9.6 | 5,000 | Indirect | |
| Dec 30, 2025 | Common Stock | SSaleDisposed | −12 | $0.64 | −$7.68 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.